[ Price : $8.95]
Akebia Therapeutics completes an End of Dispute Type A meeting with FDA that discussed the companys upcoming NDA resubmission for ...[ Price : $8.95]
Medtronic recalls its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators with glassed fe...[ Price : $8.95]
Olympus recalls about 1,500 OES BronchoFiberscope BF Type devices after receiving complaints of endobronchial combustion during th...[ Price : $8.95]
Four drug stakeholders suggest changes to a draft FDA guidance on scientific considerations in pediatric drug development.[ Price : $8.95]
A Government Accountability Office report on the challenges of regenerative medicine therapies and technologies offers 11 policy o...[ Price : $8.95]
FDA accepts for review an Elevar Therapeutics NDA for rivoceranib, an oral tyrosine kinase inhibitor in combination with camrelizu...[ Price : $8.95]
FDA gives Catalent a four-page Form FDA-483 after inspecting the firms Bloomington, IN manufacturing facility 5/4-12.[ Price : $8.95]
Quidel Cardiovascular recalls the Quidel Triage Cardiac Panel after reports of inaccurate tests showing lower-than-expected tropon...